Zobrazeno 91 - 100
of 444
pro vyhledávání: '"Kyu-pyo Kim"'
Autor:
Sora Kang, Changhoon Yoo, So Heun Lee, Heung-Moon Chang, Jae Ho Jeong, Kyu-Pyo Kim, Baek-Yeol Ryoo
Publikováno v:
Journal of Clinical Oncology. 40:547-547
547 Background: For patients who underwent curative-intent upfront surgery, adjuvant chemotherapy is the current standard of care. The previous, randomized phase 3 ESPAC-4 study showed significantly improved overall survival (OS) with GEMCAP compared
Autor:
Sora Kang, Changhoon Yoo, So Heun Lee, Dongwook Oh, Tae Jun Song, Sang Soo Lee, Jae Ho Jeong, Do Hyun Park, Dong Wan Seo, Jin-hong Park, Dae Wook Hwang, Ki Byung Song, Jae Hoon Lee, Woohyung Lee, Bong Jun Kwak, Sarang Hong, Heung-Moon Chang, Baek-Yeol Ryoo, Kyu-pyo Kim, Song Cheol Kim
Publikováno v:
Therapeutic Advances in Medical Oncology. 14:175883592210971
Background: Adjuvant chemotherapy is the standard treatment after curative-intent surgery for pancreatic ductal adenocarcinoma (PDAC). The phase-3 ESPAC-4 trial demonstrated significantly improved overall survival (OS) with Gemcitabine plus capecitab
Autor:
Minkyu Jung, Robert Piskol, Amanda R. Moore, Frances Shanahan, Jianping Yin, Hye Sook Han, Yong Sang Hong, Hyeong Seok Lim, Thomas Hunsaker, Darlene Dela Cruz, Zora Modrusan, Liangxuan Zhang, Scott E. Martin, Ehud Segal, Nicholas P. D. Liau, Tae Won Kim, Jeeyun Lee, Christiaan Klijn, Munjeong Choi, Sang Joon Shin, Young Su Noh, Soo Jung Lee, Ivana Yen, Malgorzata Nowicka, Avinashnarayan Venkatanarayan, Yibing Yan, Xin Ye, Shrividhya Srinivasan, Kyu Pyo Kim, Seung Tae Kim, Jin-Soo Kim, Matthew T. Chang, Shiva Malek, Yu Jung Kim, Oakpil Han, Eva Lin, Inhwan Bae, Yoon hee Hong, Jawahar Sudhamsu
Publikováno v:
Nature. 594(7863)
Although RAF monomer inhibitors (type I.5, BRAF(V600)) are clinically approved for the treatment of BRAFV600-mutant melanoma, they are ineffective in non-BRAFV600 mutant cells1–3. Belvarafenib is a potent and selective RAF dimer (type II) inhibitor
Autor:
Seon-Ok Kim, Jae Ho Byun, Changhoon Yoo, Ki Byung Song, Kyu-Pyo Kim, Dong Wook Kim, Jin Hee Kim, Song Cheol Kim, Hyoung Jung Kim, Seung Soo Lee
Publikováno v:
Radiology. 296(3)
Background No preoperative model is available for predicting postsurgical prognosis of patients with resectable pancreatic ductal adenocarcinoma (PDAC). Purpose To develop and validate a preoperative risk scoring system using clinical and CT variable
Autor:
Tae Won Kim, Jeong Eun Kim, Jin Cheon Kim, Yong Sang Hong, Seok-Byung Lim, Jong Hoon Kim, Sun Young Kim, Chang Sik Yu, Hyungwoo Cho, Kyu-Pyo Kim, Jin-Hong Park
Publikováno v:
Oncol Lett
The present study aimed to compare the pattern of distant recurrence between patients with non-metastatic rectal cancer treated with pre-operative (OP) and those treated with post-operative (post-OP) chemoradiotherapy (CRT). A total of 631 patients w
Autor:
Heung-Moon Chang, Jaewoo Kwon, Woohyung Lee, Kyu-Pyo Kim, Yejong Park, Eunsung Jun, Jae Hoon Lee, Seo Young Park, Dae Wook Hwang, Jae Ho Jeong, Baek-Yeol Ryoo, Song Cheol Kim, Changhoon Yoo, Ki Byung Song
Publikováno v:
Journal of Clinical Medicine
Volume 9
Issue 5
Journal of Clinical Medicine, Vol 9, Iss 1477, p 1477 (2020)
Volume 9
Issue 5
Journal of Clinical Medicine, Vol 9, Iss 1477, p 1477 (2020)
Background: The association between optimal carbohydrate antigen (CA) 19-9 concentration after neoadjuvant chemotherapy (NACT) and prognosis has not been confirmed in patients with borderline resectable (BRPC) and locally advanced pancreatic cancer (
Autor:
Changhoon Yoo, Hyehyun Jeong, Myoung Joo Kang, Baek-Yeol Ryoo, Jaekyung Cheon, Hyewon Ryu, Heejung Chae, Hong Jae Chon, Jae Ho Jeong, Il Hwan Kim, Kyu-Pyo Kim
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Therapeutic Advances in Medical Oncology
Therapeutic Advances in Medical Oncology
Background: FOLFIRINOX (fluorouracil, folinic acid, irinotecan plus oxaliplatin) is an effective standard first-line treatment option for advanced pancreatic ductal adenocarcinoma (PDAC). There is no clear consensus on the second-line treatment follo
Autor:
Song Cheol Kim, Baek-Yeol Ryoo, Hyoung Jung Kim, Changhoon Yoo, Jae Ho Byun, Seung Soo Lee, Ji Hun Kang, Jin Hee Kim, Kyu-Pyo Kim
Publikováno v:
European radiology. 31(2)
To identify multiparametric MRI biomarkers to predict the tumor response to neoadjuvant FOLFIRINOX therapy in patients with borderline resectable (BR) or locally advanced (LA) pancreatic ductal adenocarcinoma (PDAC). From May 2016 to March 2018, adul
Autor:
Changhoon Yoo, Inhwan Hwang, Song, Tae Jun, Lee, Sang Soo, Jeong, Jae Ho, Park, Do Hyun, Seo, Dong Wan, Lee, Sung Koo, Myung-Hwan Kim, Byun, Jae Ho, Park, Jin-Hong, Hwang, Dae Wook, Song, Ki Byung, Lee, Jae Hoon, Woohyung Lee, Heung-Moon Chang, Kyu-Pyo Kim, Kim, Song Cheol, Baek-Yeol Ryoo
Supplemental material, Supplementary_Table for FOLFIRINOX in borderline resectable and locally advanced unresectable pancreatic adenocarcinoma by Changhoon Yoo, Inhwan Hwang, Tae Jun Song, Sang Soo Lee, Jae Ho Jeong, Do Hyun Park, Dong Wan Seo, Sung
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::222a3bf442f9cfcf358de7e0fbd12b73
Autor:
Jwa Hoon, Kim, Seyoung, Seo, Kyu-Pyo, Kim, Heung-Moon, Chang, Baek-Yeol, Ryoo, Changhoon, Yoo, Jae Ho, Jeong, Jae-Lyun, Lee, Hyeon-Su, Im, Hyehyun, Jeong, Yeonghak, Bang, Sook Ryun, Park
Publikováno v:
In vivo (Athens, Greece). 34(2)
Background/Aim: The aim of this study was to examine the efficacy and safety of direct oral anticoagulants for cancer-associated venous thromboembolism (VTE) in patients with active cancer. Patients and Methods: This study included patients with adva